Vaxart Inc. (NASDAQ:VXRT) does about 26.11M shares in volume on a normal day but saw 8514179 shares change hands in Friday trading. The company now has a market cap of 686.92M USD. Its current market price is $6.23, marking a decrease of -0.95% compared to the previous close of $6.29. The 52 week high reached by this stock is $17.49 whilst the lowest price level in 52 weeks is $0.25. The script in recent trading has seen the stock touch a high of $6.41 and a low of $5.882.
Vaxart Inc. (VXRT) has a 20-day trading average at $8.66 and the current price is -64.38% off the 52-week high compared with 2349.86% distance from its 52-week low. The 50-day simple moving average of the closing price is $9.35 and its 200-day simple moving average is $3.48. If we look at the stock’s price movements over the week, volatility stands at 10.94%, which increases to 11.59% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 35.92 to suggest the stock is neutral.
3 analysts observing the Vaxart Inc. (VXRT) stock have set the 12-month price targets for the company’s shares at between $17.00 and $22.00. The median price target is 68.85% away from the current levels at $20.00.
FactSet Research has provided data showing that 3 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 3 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Moderate Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on August 12, 2020 when H.C. Wainwright reiterated the stock to “Buy” and issued a price target of between $7 and $17.
The current price level is -29.32%, -32.84%, and 80.53% away from its SMA20, SMA50, and SMA200 respectively, with the VXRT price moving above the 50-day SMA on August 28. Vaxart Inc. (VXRT) stock is down -24.21% over the week and -37.20% over the past month. Its price is 1677.46% year-to-date and 776.97% over the past year.
The stock last released its quarterly earnings report for quarter ended 6/29/2020, with the company’s earnings per share (EPS) of -$0.12 below consensus estimates by -$0.06. The company’s next earnings report is expected on 11/06/2020, with forecasts estimating quarterly EPS at -$0.09 and -$0.35 for whole year. VXRT’s earnings per share are forecast to grow by 59.30% this year and 14.30% over next year. Expected sales for next quarter are $2.9 million, which analysts say will come at $7.41 million for the current fiscal year and next year at $40.73 million. In addition, estimates put the company’s current quarterly revenue at an average of $1.17 million.
Its 12-month price target is $20.00. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $17.00, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $22.00.
Outstanding shares total 109.20M with insiders holding 1.21% of the shares and institutional holders owning 36.23% of the company’s common stock. The company has a return on investment of -126.00% and return on equity of -84.90%. The beta has a value of 0.02. Price to book ratio is 11.54 and price to sales ratio is 88.07.
According to a U.S. Securities and Exchange Commission filing, iShares Russell 2000 ETF has reduced its position in Vaxart Inc. (VXRT) to 913,995 shares, mirroring a recent drop by -4.48%. iShares Russell 2000 ETF dumped 42840.0 shares of Vaxart Inc. common stock bringing its total worth to about $8.58 million at the end of recent close, SEC documents show. iShares Russell 2000 ETF isn’t the only investment manager who changed stakes and is followed by Vanguard Extended Market Index Fu, which added 0.27 million shares to end up with 886,407 shares worth $8.32 million. iShares Russell 2000 Growth ETF cut their holdings by -0.97% in the company over the course of the most recent quarter. It now holds a 0.47% position in Vaxart Inc. thanks to 0.35 million shares amounting to $3.27 million.